ES2186952T3 - Esmalte para uñas de efecto antipsoriasico. - Google Patents

Esmalte para uñas de efecto antipsoriasico.

Info

Publication number
ES2186952T3
ES2186952T3 ES98115049T ES98115049T ES2186952T3 ES 2186952 T3 ES2186952 T3 ES 2186952T3 ES 98115049 T ES98115049 T ES 98115049T ES 98115049 T ES98115049 T ES 98115049T ES 2186952 T3 ES2186952 T3 ES 2186952T3
Authority
ES
Spain
Prior art keywords
antipsoriasic
enamel
nails
effect
nail
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98115049T
Other languages
English (en)
Spanish (es)
Inventor
Manfred Dr Bohn
Karl Theodor Dr Kraemer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Application granted granted Critical
Publication of ES2186952T3 publication Critical patent/ES2186952T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Finger-Pressure Massage (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES98115049T 1997-08-21 1998-08-11 Esmalte para uñas de efecto antipsoriasico. Expired - Lifetime ES2186952T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19736112 1997-08-21

Publications (1)

Publication Number Publication Date
ES2186952T3 true ES2186952T3 (es) 2003-05-16

Family

ID=7839551

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98115049T Expired - Lifetime ES2186952T3 (es) 1997-08-21 1998-08-11 Esmalte para uñas de efecto antipsoriasico.

Country Status (35)

Country Link
US (3) US6352686B2 (enExample)
EP (1) EP0913154B1 (enExample)
JP (1) JPH11130679A (enExample)
KR (1) KR100610517B1 (enExample)
CN (1) CN1155386C (enExample)
AR (1) AR015933A1 (enExample)
AT (1) ATE227993T1 (enExample)
AU (1) AU740615B2 (enExample)
BG (1) BG63270B1 (enExample)
BR (1) BR9803756A (enExample)
CA (1) CA2245637C (enExample)
CO (1) CO4960649A1 (enExample)
CZ (1) CZ292344B6 (enExample)
DE (1) DE59806343D1 (enExample)
DK (1) DK0913154T3 (enExample)
ES (1) ES2186952T3 (enExample)
HR (1) HRP980458B1 (enExample)
HU (1) HUP9801898A3 (enExample)
ID (1) ID20731A (enExample)
IL (1) IL125854A (enExample)
MY (1) MY128558A (enExample)
NO (1) NO319391B1 (enExample)
NZ (1) NZ331443A (enExample)
PL (1) PL192342B1 (enExample)
PT (1) PT913154E (enExample)
RO (1) RO118174B1 (enExample)
RU (1) RU2210354C2 (enExample)
SG (1) SG68072A1 (enExample)
SI (1) SI0913154T1 (enExample)
SK (1) SK284218B6 (enExample)
TR (1) TR199801609A2 (enExample)
TW (1) TW590776B (enExample)
UA (1) UA51693C2 (enExample)
YU (1) YU49492B (enExample)
ZA (1) ZA987531B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
WO2002055023A2 (en) * 2001-01-09 2002-07-18 Israel Dvoretzky Therapeutic film forming composition and treatment system
FR2830449B1 (fr) * 2001-10-05 2004-04-23 Fabre Pierre Dermo Cosmetique Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant
FR2835180B1 (fr) * 2002-01-30 2004-04-09 Fiabila Vernis a ongles multiphase
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
AU2003294027B2 (en) * 2002-12-17 2009-09-10 Galderma S.A. Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
EP1854466A1 (en) * 2002-12-17 2007-11-14 Galderma Research & Development, S.N.C. Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate
FR2848454B1 (fr) * 2002-12-17 2007-03-30 Galderma Res & Dev Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
US7238533B1 (en) * 2003-07-22 2007-07-03 Ronald Legge Personal illicit drug detection method
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
JP4608618B2 (ja) * 2004-07-02 2011-01-12 有限会社 エヌ・ピィ・アール ネイルアート用溶液
US20060062982A1 (en) * 2004-09-17 2006-03-23 Massachusetts Institute Of Technology Carbon-polymer electrochemical systems and methods of fabricating them using layer-by-layer technology
CA2498623A1 (en) * 2005-02-18 2006-08-18 Qlt Inc. Treatment of onychomycosis
FR2884419B1 (fr) * 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
US8277780B2 (en) * 2005-05-27 2012-10-02 Taro Pharmaceutical North America, Inc. Stable liquid desoximethasone compositions with reduced oxidized impurity
KR100803926B1 (ko) 2006-07-27 2008-02-15 주식회사 코리아나화장품 샌드프리 화장료 조성물
US20090317341A1 (en) * 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
FR2937250B1 (fr) * 2008-10-21 2013-05-10 Fabre Pierre Dermo Cosmetique Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
PT3403654T (pt) 2009-10-01 2019-09-05 Adare Dev I L P Composições de corticosteroide administradas oralmente
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
PL233616B1 (pl) 2017-08-10 2019-11-29 Podopharm Spolka Z Ograniczona Odpowiedzialnoscia Preparat do paznokci, dloni i stop oraz sposob wytwarzania tego preparatu
US20250332120A1 (en) * 2022-07-28 2025-10-30 Kao Corporation Composition for external preparation

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928261A (en) * 1973-05-17 1975-12-23 Minnesota Mining & Mfg Water removable film-forming compositions for topical application to skin
US3861932A (en) * 1973-12-13 1975-01-21 Revlon Stabilization of nitrocellulose
US3966924A (en) * 1974-11-13 1976-06-29 Allergan Pharmaceuticals Composition and method for treating psoriasis
US4179304A (en) * 1978-04-03 1979-12-18 Polychrome Corporation Finger nail lacquer
US4210633A (en) * 1978-10-20 1980-07-01 Eli Lilly And Company Flurandrenolide film formulation
US4250164A (en) * 1979-04-09 1981-02-10 Bernstein Joel E Method of treating psoriasis of the nails and composition
AU599064B2 (en) * 1985-11-04 1990-07-12 Dermatological Products Of Texas Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
DE3612305A1 (de) * 1986-04-11 1987-10-22 Roehm Pharma Gmbh Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US5093108A (en) * 1989-02-16 1992-03-03 Amalia, Inc. Quick-drying nail enamel compositions and method for coating a surface
CA2008775C (en) * 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
US5258186A (en) * 1989-03-10 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Drug release controlling coating material for long acting formulations
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE19518262A1 (de) * 1995-05-18 1996-11-21 Hoechst Ag Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen
KR100200447B1 (ko) * 1993-07-28 1999-06-15 디. 제이. 우드, 스피겔 알렌 제이 건선의 치료를 위한 조성물
DK128494A (da) * 1994-11-08 1996-05-09 Edel K Seidenschnur Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat
DE19529085A1 (de) * 1995-08-08 1997-02-13 Christiane Dr Med Wurdel Nagellack zur Bekämpfung der Schuppenflechte im Nagelbereich
JP2000512265A (ja) * 1996-03-16 2000-09-19 ヘキスト・アクチエンゲゼルシヤフト 爪の乾癬の治療のための局所投与用製剤
GB9609653D0 (en) 1996-05-09 1996-07-10 Applied Research Ars Holding N Method of assay
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia

Also Published As

Publication number Publication date
CO4960649A1 (es) 2000-09-25
AU740615B2 (en) 2001-11-08
CA2245637A1 (en) 1999-02-21
RU2210354C2 (ru) 2003-08-20
HRP980458B1 (en) 2002-12-31
KR19990023719A (ko) 1999-03-25
US20040071645A1 (en) 2004-04-15
CA2245637C (en) 2008-07-15
JPH11130679A (ja) 1999-05-18
HUP9801898A3 (en) 2000-01-28
TR199801609A3 (tr) 1999-03-22
AU8085698A (en) 1999-03-04
NO983818D0 (no) 1998-08-20
IL125854A (en) 2004-02-19
SI0913154T1 (en) 2003-04-30
NZ331443A (en) 1999-01-28
SG68072A1 (en) 1999-10-19
BG102696A (en) 1999-04-30
PL328122A1 (en) 1999-03-01
YU49492B (sh) 2006-08-17
SK284218B6 (en) 2004-11-03
EP0913154B1 (de) 2002-11-20
US20020071815A1 (en) 2002-06-13
EP0913154A1 (de) 1999-05-06
YU34998A (sh) 2002-11-15
ID20731A (id) 1999-02-25
CN1155386C (zh) 2004-06-30
SK114398A3 (en) 1999-03-12
MY128558A (en) 2007-02-28
HUP9801898A1 (hu) 1999-04-28
ATE227993T1 (de) 2002-12-15
DK0913154T3 (da) 2003-03-03
IL125854A0 (en) 1999-04-11
BR9803756A (pt) 2000-03-28
CZ292344B6 (cs) 2003-09-17
PL192342B1 (pl) 2006-10-31
BG63270B1 (bg) 2001-08-31
PT913154E (pt) 2003-04-30
NO983818L (no) 1999-02-22
ZA987531B (en) 1999-02-22
NO319391B1 (no) 2005-08-08
TR199801609A2 (xx) 1999-03-22
CZ263298A3 (cs) 1999-03-17
US6352686B2 (en) 2002-03-05
CN1209318A (zh) 1999-03-03
UA51693C2 (uk) 2002-12-16
HK1018214A1 (en) 1999-12-17
HRP980458A2 (en) 1999-06-30
KR100610517B1 (ko) 2007-04-25
DE59806343D1 (de) 2003-01-02
TW590776B (en) 2004-06-11
RO118174B1 (ro) 2003-03-28
US20010006625A1 (en) 2001-07-05
HU9801898D0 (en) 1998-10-28
AR015933A1 (es) 2001-05-30

Similar Documents

Publication Publication Date Title
ES2186952T3 (es) Esmalte para uñas de efecto antipsoriasico.
DE69717095D1 (de) Topische vitamin d zusammensetzung auf liposomenbasis
ES2195970T3 (es) L-ribavirina y usos de la misma.
NO974480D0 (no) Anvendelse av vitamin D2 eller vitamin D4 derivater til fremstilling av et medikament for behandling av sekundær hyperparathyreoidisme
NO20000606L (no) Arkmateriale egnet for anvendelse som gulv, vegg eller takbekledningsmateriale, og fremgangsmåte og mellomprodukt for fremstilling derav
DE69531834D1 (de) Herstellung einer aerosolformulierung von insulin
DE69623472D1 (de) Derivate von dolastatin, dreen herstellung un verwendung
NO20056021L (no) Anvendelse av CS-866 til fremstilling av et medikament
ATE178201T1 (de) Alkoholisches feuchtigkeitsspendendes after shave lotion
DE69504780D1 (de) Nietnägel, sowie anwendungsverfahren
ES2179138T3 (es) Poliisocianatos que presentan grupos alofanato basados en difenilmetanodiisocianato con grupos isocianato predominante o completamente bloqueados.
PT989973E (pt) Calconas possuindo actividade antiproliferativa
BR9813996A (pt) 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio
DE59602691D1 (de) Herstellung von primären Guerbetaminen
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.
ZA972180B (en) Topical formulations for the treatment of psoriasis of the nail.
PA7801701A1 (es) Compuestos ariltios
CL2004001291A1 (es) Composicion farmaceutica que comprende compuestos carbociclicos y heterociclicos; y su uso para el tratamiento o profilaxis de la infeccion por influenza.
ES2160893T3 (es) Procedimiento y compuestos intermedios para la preparacion de compuestos de fluoroolefinas plaguicidas.
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
GT198400017A (es) Metodo para la preparacion de 8 metoxi -4,8 - dimetil -1-(4-isopropilfenil)-nonano.
ES2152490T3 (es) Transformacion de 8-cloroquinoleinas sustituidas en 8-hidroxiquinoleinas sustituidas.
MX9304971A (es) PROCEDIMIENTO PARA SINTETIZAR UN ACIDO ß-AMINOALQUILBORONICO Y EL ESTER.
ES2062492T3 (es) 2-(n-acil)amino-6,7-dimetoxi tetralinas, procedimiento para su preparacion y composiciones farmaceuticas con actividad antihipertensiva que las contienen.
ES2079650T3 (es) Acido 4-((tiofeno-2-carbonil)oxi)pirrolidin-2-carboxilico, su preparacion y su uso como agente antiinflamatorio y antidistrofico.